Development of transferrin-bearing vesicles encapsulating aspirin for cancer therapy

References

• Aldawsari, H., et al., 2011. Enhanced gene expression in tumors after intravenous administration of arginine, lysine- and leucine-bearing polypropylenimine polyplex. Biomaterials, 32(25), 5889–5899.
   PubMed Web of Science ®Google Scholar
• Alfonso, L., et al., 2014. Molecular targets of aspirin and cancer prevention. British journal of cancer, 111(1), 61–67.
   PubMed Web of Science ®Google Scholar
• Alshehri, A., Grabowska, A., and Stolnik, S., 2018. Pathways of cellular internalisation of liposomes delivered siRNA and effects on siRNA engagement with target mRNA and silencing in cancer cells. Scientific reports, 8(1), 3748.
   PubMed Web of Science ®Google Scholar
• Ashktorab, H., et al., 2005. Apoptosis induced by aspirin and 5-fluorouracil in human colonic adenocarcinoma cells. Digestive diseases and sciences, 50(6), 1025–2032.
   PubMed Web of Science ®Google Scholar
• Bolkestein, M., et al., 2016. Investigation of factors determining the enhanced permeability and retention effect in subcutaneous xenografts. Journal of nuclear medicine, 57(4), 601–607.
   PubMed Web of Science ®Google Scholar
• Calzolari, A., et al., 2007. Transferrin receptor 2 is frequently expressed in human cancer cell lines. Blood cells, molecules & diseases, 39(1), 82–91.
   PubMed Web of Science ®Google Scholar
• Čeh, B., et al., 1997. Stealth liposomes: from theory to product. Advanced drug delivery reviews, 24(2–3), 165–177.
   Web of Science ®Google Scholar
• Costello, P.B., and Green, F.A., 1982. Aspirin survival in human blood modulated by the concentration of erythrocytes. Arthritis & rheumatology, 25(5), 550.
   PubMed Web of Science ®Google Scholar
• Daniels, T.R., et al., 2006. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clinical immunology, 121 (2), 159–176.
   PubMed Web of Science ®Google Scholar
• Das, S., et al., 2005. Aspirin loaded albumin nanoparticles by coacervation: implications in drug delivery. Trends in biomaterials and artificial organs, 18, 203–207.
   Google Scholar
• Dong, C., and Rogers, J.A., 1992. Poly(4-vinylpyridine)-coated liposomes: stability studies and release of acetylsalicylic acid. Journal of microencapsulation, 9(4), 437–448.
   PubMed Web of Science ®Google Scholar
• Dong, C., and Rogers, J.A., 1993. Acacia-gelatin microencapsulated liposomes: preparation, stability, and release of acetylsalicylic acid. Pharmaceutical research, 10(1), 141–146.
   PubMed Web of Science ®Google Scholar
• Dufès, C., et al., 2000. Niosomes and polymeric chitosan based vesicles bearing transferrin and glucose ligands for drug targeting. Pharmaceutical research, 17, 1250–1258.
   PubMed Web of Science ®Google Scholar
• Dufès, C., et al., 2004. Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles. Pharmaceutical research, 21, 101–107.
   PubMed Web of Science ®Google Scholar
• Fu, J.Y., et al., 2009. Tumor regression after systemic administration of tocotrienol entrapped in tumor-targeted vesicles. Journal of control release, 140(2), 95–99.
   PubMed Web of Science ®Google Scholar
• Fu, J.Y., et al., 2011. Novel tocotrienol-entrapping vesicles can eradicate solid tumors after intravenous administration. Journal of controlled release : official journal of the controlled release society, 154(1), 20–26.
   PubMed Web of Science ®Google Scholar
• Hefesha, H., et al., 2011. Transfer mechanism of temoporfin between liposomal membranes. Journal of controlled release : official journal of the controlled release society, 150(3), 279–286.
   PubMed Web of Science ®Google Scholar
• Karim, R., et al., 2017. Tumor regression after intravenous administration of targeted vesicles entrapping the vitamin E α-tocotrienol. Journal of controlled release : official journal of the controlled release society, 246, 79–87.
   PubMed Web of Science ®Google Scholar
• Kierys, A., 2014. Synthesis of aspirin-loaded polymer-silica composites and their release characteristics. ACS applied materials and interfaces, 6(16), 14369–14376.
   PubMed Web of Science ®Google Scholar
• Kutuk, O., and Basaga, H., 2003. Aspirin prevents apoptosis and NF-κB activation induced by H2O2 in HeLa cells. Free radical research, 37 (12), 1267–1276.
   PubMed Web of Science ®Google Scholar
• Lamb, D.J., and Leake, D.S., 1994. Iron released from transferrin at acidic pH can catalyse the oxidation of low density lipoprotein. FEBS letters, 352(1), 15–18.
   PubMed Web of Science ®Google Scholar
• Lemarié, F., et al., 2012. Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system. Biomaterials, 33 (9), 2701–2709.
   PubMed Web of Science ®Google Scholar
• Maeda, H., 1992. The tumor blood vessel as an ideal target for macromolecular anticancer agents. Journal of controlled release : official journal of the controlled release society, 19(1–3), 315–324.
   Google Scholar
• Park, I.S., et al., 2010. Aspirin induces apoptosis in YD-8 human oral squamous carcinoma cells through activation of caspases, down-regulation of Mcl-1, and inactivation of ERK-1/2 and AKT. Toxicology in vitro, 24(3), 713–720.
   PubMed Web of Science ®Google Scholar
• Paszko, E., et al., 2013. Transferrin conjugation does not increase the efficiency of liposomal Foscan during in vitro photodynamic therapy of oesophageal cancer. European journal of pharmaceutical sciences, 48(1–2), 202–210.
   PubMed Web of Science ®Google Scholar
• Qian, Z.M., et al., 2002. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacological reviews, 54(4), 561–587.
   PubMed Web of Science ®Google Scholar
• Richardson, D.R., and Ponka, P., 1997. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochimica et biophysica acta, 1331(1), 1–40.
   PubMed Web of Science ®Google Scholar
• Rose, P.W., et al., 2011. Aspirin for prevention of cancer and cardiovascular disease. The British journal of general practice, 61(587), 412–415.
   PubMed Web of Science ®Google Scholar
• Rothwell, P.M., et al., 2011. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. The lancet, 377(9759), 31–41.
   PubMed Web of Science ®Google Scholar
• Sercombe, L., et al., 2015. Advances and challenges of liposome assisted drug delivery. Frontiers in pharmacology, 6, 286.
   PubMed Web of Science ®Google Scholar
• Stark, L.A., et al., 2006. Aspirin activates the NF-κB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer. Carcinogenesis, 28(5), 968–976.
   PubMed Web of Science ®Google Scholar
• Sutaria, D., et al., 2012. Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen. International journal of oncology, 41(6), 2260–2268.
   PubMed Web of Science ®Google Scholar
• Voutsadakis, I.A., et al., 2010. Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib. International journal of colorectal disease, 25(7), 795–804.
   PubMed Web of Science ®Google Scholar
• Xiang, S., et al., 2010. Aspirin inhibits ErbB2 to induce apoptosis in cervical cancer cells. Medical oncology (Northwood, London, England), 27 (2), 379–387.
   PubMed Web of Science ®Google Scholar
• Yuan, F., et al., 1995. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer research, 55(17), 3752–3756.
   PubMed Web of Science ®Google Scholar
• Zhou, L., et al., 2015. Co-delivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis. International journal of nanomedicine, 10, 5205–5218.
   PubMed Web of Science ®Google Scholar